Specific serum antibody levels in Leishmania infantum-infected dogs treated with a combination of glucantime and allopurinol were estimated by indirect immunofluorescence and Western blotting. The sensitivity of Western blot was greater than that obtained with immunofluorescence titration. In general, both diagnostic methods concurred with the post-treatment clinical status of the animals. Clinical improvement of successfully treated dogs was related to lower immunofluorescence titers and simpler and/or less reactive immunodetection patterns in Western blotting. The recognition, by infected dogs, of certain low molecular weight antigens, particularly one of approximately 26 kDa, was restricted to pretreatment samples and a single animal in relapse thus apparently constituting an active infection marker.
Human infection by Leishmania infantum in the western Mediterranean basin has traditionally been linked to children. 18 In the last few years, however, a rise in the incidence of this disease has been observed in the area 14 particulary in HIV-positive patients. 2 The disease is a zoonotic infection for which dogs are the most important reservoir. An average prevalence ranging from 5% to 8% of the total canine population has been reported, with Ͼ30% in some locations. 1, 15 An integrated approach to control of leishmaniasis in the region must include the control of canine infections. Moreover, canine leishmaniasis is of principle interest to many veterinary practitioners.
Clinical diagnosis of infected dogs is generally based on the clinical signs (depilations, lymphadenopathy, emaciation, hepatosplenomegaly), serum protein levels, proteinogram (albumin/globulin index), and indirect fluorescent antibody titration (IFAT). 4, 6, 13, 17 Although these diagnostic methods are useful, the identification of a marker for active L. infantum infection would be of use in epidemiologic studies and clinical practice.
In experimentally infected dogs, some low-molecular-weight (LMW) parasite antigens were identified coincident with peak IFAT values and the more severe biopathologic changes. 8 If these recognition patterns were confirmed in natural infections, they could be used advantageously to determine the prognosis of the infected dogs. Here, we describe the results obtained by IFAT and Western blotting (WB) when determining the serum antibody response to L. infantum in naturally infected dogs after chemotherapeutic treatment.
Materials and methods

Sera from naturally infected dogs.
Sera from 11 naturally infected dogs were obtained at the Clinical Services of Infectious and Parasitic Diseases (Facultad de Veterinaria, Madrid, Spain). The initial clinical status of the dogs is shown in Table 1 . Animals were treated with a combination of meglumine antimoniate (glucantime) (75-150 mg/kg/day) and allopurinol (5-25 mg/kg/day), depending on clinical considerations, except for animal 2, which did not tolerate allopurinol and only received glucantime. The treatment produced clinical improvement in 10 of 11 animals, but animal 10 relapsed.
IFAT titration. The parasite-specific serum antibody response was determined by IFAT. The test was performed using acetone-fixed stationary phase promastigotes of a local strain of L. infantum (DOBA; MCAN/ES/88/ISS441); canine sera were diluted (1:50 to 1:6,400) in phosphate-buffered saline (PBS). After incubation, the second antibody (fluorescein-labeled anti-dog lgG) a diluted 1:100 in PBS was added. Sera with titers over 1:100 were considered positive.
Electrophoresis and Western blotting. Late logarithmic phase promastigotes of the same L. infantum strain were used to obtain the soluble antigenic extract. Promastigotes cultured at 26 C in Grace medium with 10% fetal bovine serum b , 100 IU penicillin, and 100 g/ml streptomycin c were harvested and washed extensively (centrifuged at 800 ϫ g) in PBS. Protein extracts were obtained by freezing and thawing cycles (Ϫ80 C and room temperature). Homogenates were centrifuged (15,000 ϫ g, 15 minutes, 4 C) before supernatants were used. Protein yield was determined, 5 and protein fractionation was carried out in slab polyacrylamide (12.5%) gels under denaturing and reducing conditions (sodium dodecyl sulfate-polyacrylamide gel electrophoresis SDS-PAGE), at a protein concentration of 1 mg/ml loaded over the gel. Western blotting (WB) was carried out as previously described. 9 After overnight electroblotting, nitrocellulose membranes d were probed with dog sera diluted 1:100 for 3 hours. After washing, the second antibody (horseradish peroxidase-labeled rabbit anti-dog IgG, 1:1,000) a was ap- 
Results
IFAT titers. Results of IFAT for L. infantum-infected dogs throughout the chemotherapeutic treatment period are shown in Table 2 . Pretreatment IFAT results were variable, ranging from 1:6400 (dogs 3, 7, 9, 10) to only slightly positive (1:200, dog 4), with intermediate values in the rest of the animals. No clear correlation was observed between initial clinical status (see Table 1 ) and pretreatment IFAT result because some dogs that displayed only mild signs (dog 6: periorbital depilations, slight lymphadenopathy) had high titers (1:800), whereas the same IFAT result was found in dogs with more advanced disease (dog 8).
Treatment produced a drop in IFAT value, except in dog 10, which relapsed 8 months after treatment, and dog 4, which had a slight rise in titer for 5 months posttreatment. Clinical improvement of treated animals was evident in the first analysis after initiation of treatment. Notable variations were found in the elapsed posttreatment time required to observe IFAT reductions and were obvious in some dogs (nos. 7, 8, 9) very early (2 months posttreatment), whereas other dogs (nos. 1, 2) maintained pretreatment IFAT values for longer periods.
Western blotting analysis. WB recognition patterns obtained with the sera of untreated naturally infected dogs were certain similar ( Fig. 1) , with immunodominant bands at 67, 50-57, 45, 42, 35.4, 34, 29, and 26 kDa. All dogs except dog 2 showed a strong band at 67 kDa in the pretreatment sample that was maintained, although with variable intensity, throughout the study period. Comparable results were observed for the 29-kDa peptide. There was a marked loss of reactivity after treatment, depending on the an-tigens considered. The recognition of the 26-and 34-35. 4-kDa polypeptides showed, in general, a rapid response to chemotherapy when they were present before starting treatment. The sera from 8 of 11 dogs produced bands in at least 1 of these 2 regions.
The immunodetection pattern of dog 1 showed strong reactivity in the 67-kDa region, which was reduced after treatment, and very weak reactivity with the other immunodominant antigens. The reactivity of sera from dog 4 was low, even before medication; however, the 67-and 45-kDa antigens were evident, as were the 34-35.4-and 26-kDa antigens, although these were very faint. tigens and showed a very weak loss of reactivity after treatment. Dog 6 serum recognized several antigens, including the 67-and 29-kDa peptides. This animal, with very mild clinical signs, showed no reactivity to the 26-kDa region before therapy. Following treatment, there was no reactivity at those levels. The immunodetection pattern of dog 7 included strong recognition of the immunodominant antigens (67, 50-57, 45, 35.4, 29, and 26 kDa). After treatment, recognition of the 29-kDa antigen was maintained, but there was only weak reactivity with 45-and 67-kDa peptides. Dog 8 serum reacted with antigens of 67, 50-57, and 29 kDa and after therapy maintained a clear recognition of the 29-kDa peptide. Dog 9 serum recognized the immunodominant antigens but after chemotherapy only showed strong reactivity in the 29-kDa region. Dog 10 serum showed strong recognition of 67-and 29-kDa antigens and a weak reactivity of 50-57, 45, 35-and 26-kDa antigens. After therapy, there was no recognition of the 26-kDa antigen, but at the time of relapse, reactivity was evident in this region. Dog 11 serum showed a clear recognition of peptides of 67, 50-57, 45, and 29 kDa. After treatment, there was a marked loss of reactivity, although this dog maintained a clear recognition of 67-and 29-kDa antigens.
Discussion
There is growing concern about the need to control canine leishmaniasis, caused by L. infantum, for public health and animal health reasons. Vaccination is presently unavailable, sandfly control is impractical, and euthanasia of infected dogs is neither compulsory nor acceptable for many veterinary practicioners and dog owners. Most infected animals in urban areas are therefore treated with a variety of agents and schedules. Successful treatment is largely dependent on early diagnosis and accurate monitoring of infected animals.
IFAT is by far the most common diagnostic method used to assess L. infantum infection in dogs, in spite of the existence of other diagnostic systems with greater sensitivity. 8, [10] [11] [12] 16 The present results confirm that IFAT underestimates the infection when compared to WB, with clear recognition of L. infantum antigens equal to or below the cutoff titer (1:100). Moreover, the estimated response by WB was generally more rapid than that by IFAT in the clinical follow-up of treated animals, expressed by a reduction in or disappearance of immunoreactivity. Both IFAT and WB results were correlated with the clinical improvement of the treated animals. 17 It has been suggested that the high antibody titers observed in medicated animals 3 are related to immunologic stimulation by surviving parasites, therefore rendering antibody monitoring of the animals useless. In the present study, as observed in allopurinoltreated dogs, 17 there was a consistent tendency toward lower IFAT values and WB reactivity in those animals with clear clinical improvements, and the relapsed dog (no. 10) displayed both a more complex WB reactivity pattern and a higher IFAT value.
A striking pattern of reactivity was found for low molecular mass antigens, particularly the 26-and 34-35.4-kDa bands. Eight of 11 dogs reacted with 1 or both regions before treatment, indicating that their recognition is restricted to active disease periods. This reactivity disappeared in parallel with the clinical improvement of the dogs and was observed in the relapsed dog (no. 10). Similar findings were obtained in experimentally infected animals, 8 suggesting that immune recognition of these polypeptides could be used as an incidence marker for epidemiologic purposes and for clinical follow-up of treated dogs. Sera from L. infantum-infected humans receiving treatment showed a comparable pattern in immunoblot studies with a 17-kDa antigen. 7 Whether or not the epitope involved is the same is unknown because different antigenic extraction methods were used. In addition to the incidence and clinical improvement character of this 26-kDa antigen recognition in WB, of great concern is the infective status of L. infantum-infected dogs once treatment is begun. The only study of the infectivity of treated dogs to sandflies 3 did not include WB analysis. All animals studied were noninfective for at least 4 months after chemotherapy with a similar combination (glucantime ϩ allopurinol); however, infective dogs were those undergoing a relapse. Given the restriction of the 26-kDa antigen recognition to periods of active infection, it seems reasonable to assume that the immunoreactivity to this protein could be used as infection marker, given the impractical use of xenodiagnosis. 3 In this study, some low-molecular-mass L. infantum antigens, in particular one of 26 kDa, were specifically recognized by sera of 8 of 11 untreated, and unsuccessfully treated dogs, apparently constituting an epidemiologic infection marker and a good prognostic aid in clinical practice. Moreover, its restriction to active infection periods suggests its potential utility in determining the infective status of L. infantum-infected animals.
